- Home
- TSAT vs JUNS Comparison
TSAT vs JUNS Comparison
Compare TSAT & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- JUNS
- Stock Information
- Founded
- TSAT 1969
- JUNS 2015
- Country
- TSAT Canada
- JUNS United States
- Employees
- TSAT N/A
- JUNS N/A
- Industry
- TSAT Metal Fabrications
- JUNS
- Sector
- TSAT Industrials
- JUNS
- Exchange
- TSAT Nasdaq
- JUNS NYSE
- Market Cap
- TSAT 233.1M
- JUNS 20.5M
- IPO Year
- TSAT 1996
- JUNS 2024
- Fundamental
- Price
- TSAT $25.84
- JUNS $1.47
- Analyst Decision
- TSAT
- JUNS
- Analyst Count
- TSAT 0
- JUNS 0
- Target Price
- TSAT N/A
- JUNS N/A
- AVG Volume (30 Days)
- TSAT 162.9K
- JUNS 1.0M
- Earning Date
- TSAT 08-13-2025
- JUNS 08-11-2025
- Dividend Yield
- TSAT N/A
- JUNS N/A
- EPS Growth
- TSAT N/A
- JUNS N/A
- EPS
- TSAT N/A
- JUNS N/A
- Revenue
- TSAT $372,642,710.00
- JUNS N/A
- Revenue This Year
- TSAT N/A
- JUNS N/A
- Revenue Next Year
- TSAT N/A
- JUNS N/A
- P/E Ratio
- TSAT N/A
- JUNS N/A
- Revenue Growth
- TSAT N/A
- JUNS N/A
- 52 Week Low
- TSAT $7.21
- JUNS $0.51
- 52 Week High
- TSAT $27.45
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- TSAT 72.06
- JUNS N/A
- Support Level
- TSAT $25.26
- JUNS N/A
- Resistance Level
- TSAT $27.45
- JUNS N/A
- Average True Range (ATR)
- TSAT 1.80
- JUNS 0.00
- MACD
- TSAT 0.18
- JUNS 0.00
- Stochastic Oscillator
- TSAT 81.75
- JUNS 0.00
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.